Vimarsana
Biggest News Aggregation in the World

Ben Chorin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ben Chorin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ben Chorin Today - Breaking & Trending Today

Skyline Announces Q2 2023 Financial Results - Vimarsana News

Skyline Announces Q2 2023 Financial Results

Skyline Announces Q2 2023 Financial Results

RedHill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results - Vimarsana News

RedHill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results

/PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported its operational...

RedHill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results - Vimarsana News

RedHill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results

/PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported its operational...

RedHill Biopharma Reports Second Quarter 2021 Financial Results and Operational Highlights - Vimarsana News

RedHill Biopharma Reports Second Quarter 2021 Financial Results and Operational Highlights

/PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported its financial results...

RedHill Biopharma Reports First Quarter 2021 Financial Results and Operational Highlights - Vimarsana News

RedHill Biopharma Reports First Quarter 2021 Financial Results and Operational Highlights

TEL AVIV, Israel and RALEIGH, N.C., May 27, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported its financial results and operational highlights for the first quarter ended March 31, 2021. Dror Ben-Asher, RedHill's Chief Executive Officer, said: "The progress of our two novel, oral COVID-19 programs has put RedHill at the forefront of oral COVID-19 therapeutics development. Opaganib, one of the most advanced and promising novel, dual-mode of action, oral drug candidates in development for COVID-19, now ...